If you have read anything about testosterone therapy for women in the last few years, you have probably encountered two completely opposite stories. One says testosterone is a forgotten miracle hormone that fixes low energy, brain fog, weak muscles, mood, and a missing sex drive. The other says it is an overhyped, unproven trend being sold to vulnerable women who deserve better. The truth sits in the uncomfortable middle, and the middle is where the actual science lives.
Testosterone is a real and important hormone in the female body, not a male hormone that women happen to carry a little of. The research on supplementing it is genuinely promising in one specific area and genuinely thin in most others. If you have been told your labs are normal but you still feel like a stranger in your own body, you deserve the full picture, including the parts that are not flattering to anyone selling a quick fix. So let’s separate what the evidence actually supports from what gets claimed in the marketing.
Do women need testosterone?
Yes. Women produce testosterone throughout their lives, and it plays a meaningful role in normal physiology. In fact, women make more testosterone than estrogen by quantity during their reproductive years, though both circulate at far lower concentrations than testosterone does in men.
Testosterone in women is produced by the ovaries and the adrenal glands, along with conversion from precursor hormones in peripheral tissues. Levels peak in a woman’s twenties and then decline gradually with age. By the time a woman reaches her forties, her circulating testosterone is roughly half of what it was two decades earlier. This decline is slow and steady, not the sharp cliff that estrogen and progesterone fall off during the menopause transition.
That gradual slope matters, because it complicates the simple narrative. There is no clean threshold where female testosterone becomes officially “low.” Researchers have not been able to define a blood level below which symptoms reliably appear. That is one reason this topic is so muddy, and one reason honest clinicians stay cautious.
What does testosterone do in a woman’s body?
Testosterone contributes to sexual desire and arousal, and it participates in the systems governing energy, mood, muscle, and bone. It does not work alone. It operates inside a web of hormones, and some of its effects in women come from its conversion into estrogen at the tissue level.
Here is where it helps to be precise. The fact that testosterone is involved in a process does not mean that adding more testosterone improves that process, especially once levels are already within a normal range. Biology is full of systems where more of a good thing does nothing useful or actively causes harm.
The table below summarizes what testosterone does physiologically in women versus what supplementing it has actually been shown to do in clinical trials.
| Role in the female body | What the evidence shows about supplementing | Evidence strength |
| Sexual desire, arousal, orgasm, satisfaction | Improves these outcomes in postmenopausal women with HSDD at physiologic doses | Strong (multiple RCTs, meta-analysis) |
| Mood and sense of well-being | Some signals, but not consistent or clinically clear | Limited / insufficient |
| Energy and fatigue | Frequently claimed, not well supported as an independent benefit | Insufficient |
| Cognition and “brain fog” | No reliable evidence of benefit | Insufficient |
| Bone density | Biologically plausible, not proven by trials | Insufficient |
| Muscle mass and strength | Minimal data in women at physiologic doses | Insufficient |
Notice how short the “strong” column is. That is not an accident, and it is not a flaw in this article. It is an honest reflection of where the research stands in 2026.
What are the signs of low testosterone in women?
The honest answer is that there is no symptom checklist that reliably points to low testosterone in women, because the same symptoms overlap with dozens of other causes. Persistent low sexual desire that causes personal distress is the symptom most closely tied to testosterone in the research. The rest are far less specific.
Women often describe a cluster: low libido, fatigue that sleep does not fix, low mood, reduced motivation, and a general sense of feeling flat. Those are real experiences. The problem is that thyroid dysfunction, iron deficiency, perimenopause, depression, chronic stress, medication side effects, and poor sleep can each produce the identical cluster.
This is exactly why a symptom list alone should never lead to a testosterone prescription. At iRevive, we treat these symptoms as the start of an investigation, not the conclusion of one. Before we ever discuss testosterone, we look at the whole picture through comprehensive biomarker analysis, including total and free testosterone, sex hormone binding globulin, and a full hormone and metabolic panel. A “normal” testosterone level alongside an obvious thyroid problem changes the entire conversation.
If you have read our companion piece, 8 Signs of Low Testosterone in Men, you already know the male version of this story is clearer. In men, deficiency is better defined and the diagnostic criteria are more established. Women are not just smaller men with the same physiology, and the science reflects that gap.
Does testosterone therapy work for women?
For one specific group, yes, and the evidence is reasonably solid. In postmenopausal women diagnosed with hypoactive sexual desire disorder (HSDD), testosterone therapy dosed to keep blood levels within the normal premenopausal female range can improve sexual desire, arousal, orgasmic function, and overall sexual satisfaction. Outside of that group and that outcome, the evidence does not hold up.
HSDD is not the same as occasionally not being in the mood. It is persistent, distressing low sexual desire that is not better explained by a relationship problem, a medication, a medical condition, or a mental health issue. The distress part matters. A woman who is content with a lower libido does not have a disorder.
The supporting data is real. A landmark trial published in the New England Journal of Medicine by Shifren and colleagues studied transdermal testosterone in surgically menopausal women with low desire and found meaningful increases in satisfying sexual activity compared with placebo. A 2019 systematic review and meta-analysis in The Lancet Diabetes and Endocrinology pooled 36 trials covering more than 8,000 women and concluded that testosterone significantly improves sexual function in postmenopausal women.
Now the limitations, because this is where most articles go quiet. That same Lancet meta-analysis found no clear, reliable benefit for cognition, mood, bone density, or general well-being. The strong evidence is for sexual function, and essentially nothing else. There are no large trials in younger or premenopausal women, so prescribing for a woman in her thirties is extrapolation, not evidence. And testosterone is not the first step for low desire. HSDD requires a full evaluation of physical, psychological, and relational causes first, because for many women the answer lies somewhere other than a hormone.
This is the part of hormone optimization that gets oversold. Testosterone is a precise tool for a specific problem, not a general-purpose tonic for feeling older.
Is testosterone therapy for women safe?
The most honest answer is that short-term safety at physiologic doses looks reasonable, but long-term safety data in women is genuinely limited. That uncertainty is not a reason for panic, and it is not a reason for casual prescribing either. It is a reason for careful dosing and ongoing monitoring.
When testosterone is dosed to keep blood levels within the normal female range, the trials have generally not shown serious harm over their study periods. The trouble is that those study periods are short, often a year or less, and women may stay on therapy for many years. We simply do not have decades of data the way we wish we did.
There are specific signals worth respecting. One analysis of more than 8,800 women found that those using testosterone along with associated supplements had a higher risk of developing type 2 diabetes. This fits a broader and well-documented pattern: in women, higher testosterone levels are associated with greater diabetes risk, which is the opposite of the relationship seen in men. That sex-specific difference is one more reason female protocols cannot be borrowed from male ones.
The most common side effects are dose-dependent and androgenic: acne, unwanted hair growth, and in some cases scalp hair thinning or voice changes. These are much more likely when levels are pushed above the physiologic female range, which is precisely what happens with high-dose pellets and aggressive protocols. Staying in range is not a minor detail. It is the safety strategy.
Delivery method matters too. Oral testosterone is discouraged because of its unfavorable effects on cholesterol and lipids. Transdermal delivery through a cream or gel is preferred across the major guidelines, because it produces a more neutral lipid profile and steadier levels.
| Consideration | What the evidence says |
| Short-term safety (physiologic dose) | Reasonable in trials, generally no serious harm observed |
| Long-term safety | Limited data, an honest unknown |
| Type 2 diabetes risk | Higher testosterone associated with increased risk in women |
| Androgenic side effects | Dose-dependent: acne, hair changes, more likely above range |
| Oral vs. transdermal | Oral discouraged (lipid effects); transdermal preferred |
Is testosterone for women FDA-approved?
No. There is currently no testosterone product approved by the FDA specifically for women in the United States. Every prescription written for a woman is therefore off-label, frequently using a compounded preparation or a fraction of a product approved for men.
This is one of the most important and least understood facts in this entire conversation. Off-label does not mean illegal or inappropriate. Physicians and qualified clinicians prescribe medications off-label every day, supported by evidence and clinical judgment. But it does mean there is no FDA-vetted, female-specific dose or product, which puts more responsibility on the prescriber to dose carefully and monitor closely.
The major medical bodies have weighed in. The 2019 Global Consensus Position Statement on the Use of Testosterone Therapy for Women, developed and endorsed by a coalition of endocrine, menopause, and sexual medicine societies, reached a narrow and specific conclusion: the only evidence-based indication for testosterone therapy in women is postmenopausal HSDD, using doses that keep blood levels within the physiologic premenopausal female range, with non-oral delivery preferred. The statement explicitly does not endorse testosterone for energy, mood, cognition, bone health, or general anti-aging purposes, because the evidence is not there.
When you see testosterone marketed for everything under the sun, that is the gap between marketing and the consensus statement. Worth knowing before you sign up anywhere.
How does iRevive approach testosterone optimization for women?
We start with evidence and a thorough workup, not with a prescription pad. Testosterone is one option we may consider for the right patient, after we understand the full hormonal and metabolic picture and have ruled out the more common explanations for how she feels.
Our process begins with comprehensive biomarker analysis that goes well beyond a single testosterone number. We assess total and free testosterone, sex hormone binding globulin, thyroid, and a full hormone and metabolic panel, because the symptom that brought you in is often driven by something other than testosterone. Many women who come to us convinced they need testosterone actually need their thyroid, iron, sleep, or perimenopausal transition addressed first. If you are still sorting out where you are in that transition, our guide on Perimenopause vs. Menopause is a good place to start.
When testosterone is genuinely appropriate, our hormone optimization protocols are built to stay within the physiologic female range, using transdermal delivery in line with the consensus guidelines, with ongoing monitoring to keep levels where they belong. The goal is never the highest number. It is the right number for your body, tracked over time and adjusted as needed.
iRevive operates as a concierge telehealth practice based in Florida, founded by Ryan Hentges, NP. That model means you are not rushed through a fifteen-minute video call with a rotating cast of providers. You work with the same clinician, you have direct access between visits, and your protocol gets adjusted based on how you actually respond and how your follow-up labs look. Membership is $99 per month. For a therapy that lives or dies on careful dosing and consistent monitoring, that relationship is not a luxury. It is the entire point.
Frequently Asked Questions
Can testosterone therapy help my low libido if I am still in perimenopause?
The strong evidence for testosterone and sexual desire comes from studies in postmenopausal women, and there are no large trials in premenopausal or perimenopausal women. That does not mean it never helps younger women, but it does mean the data is not there to support it confidently. A thorough evaluation of all the contributors to low desire should come first.
Will testosterone give me more energy and clear my brain fog?
This is one of the most common hopes, and unfortunately the research does not support it. The 2019 Lancet meta-analysis found no reliable benefit for cognition, mood, or general well-being. Fatigue and brain fog usually trace back to thyroid issues, sleep, iron, or the hormonal shifts of perimenopause, which is why we test for those first.
Is it safe to use testosterone long term?
Short-term safety at physiologic doses looks reasonable in the trials we have, but long-term safety data in women is genuinely limited. There is also evidence linking testosterone use to higher type 2 diabetes risk in women. This is why careful dosing within the normal female range and ongoing monitoring matter so much.
Why do I need so much lab work before starting testosterone therapy?
Because the symptoms that point toward low testosterone overlap with many other conditions, and a single testosterone reading tells you very little on its own. Comprehensive biomarker analysis lets us confirm that testosterone is actually the issue, rule out other causes, and establish a baseline so we can monitor your response safely over time.
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. It is not a substitute for evaluation, diagnosis, or treatment by a qualified healthcare provider. Testosterone is not FDA-approved for use in women and is prescribed off-label. Individual results vary, and no specific outcome is guaranteed. iRevive provides care via telehealth across Florida. Do not start, stop, or change any therapy without consulting a licensed clinician who is familiar with your personal health history.
References
- Cedars-Sinai. “Testosterone Therapy for Women.” Cedars-Sinai Stories and Insights. https://www.cedars-sinai.org/stories-and-insights/expert-advice/testosterone-therapy-for-women
- Shifren JL, Davis SR, et al. “Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen.” New England Journal of Medicine, 2008. https://www.nejm.org/doi/full/10.1056/NEJMoa0707302
- Davis SR, Baber R, Panay N, et al. “Global Consensus Position Statement on the Use of Testosterone Therapy for Women.” Climacteric / Journal of Clinical Endocrinology & Metabolism, 2019. https://www.imsociety.org/wp-content/uploads/2020/07/global-consensus-testosterone-english.pdf
- Islam RM, Bell RJ, Green S, et al. “Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data.” The Lancet Diabetes & Endocrinology, 2019. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(19)30189-5/abstract
- “Testosterone and female sexual desire: a review.” PMC, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10522204/
- UT Southwestern Medical Center. “Attention women: Low sex drive? Testosterone won’t help.” UT Southwestern MedBlog. https://utswmed.org/medblog/libido-testosterone-women/
- International Society for the Study of Women’s Sexual Health. “Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.” PMC, 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8064950/
